Open Research will be unavailable from 10.15am - 11am on Saturday 14th March 2026 AEDT due to scheduled maintenance.

Lymphocytopenia as a Prognostic Marker for Diffuse Large B Cell Lymphoma

Date

Authors

Talaulikar, Dipti

Choudhury, Ayesha

Shadbolt, Bruce

Brown, Michael

Publisher

Informa Healthcare

Abstract

Lymphocytopenia has been reported to confer adverse outcomes in a number of hematological malignancies. Recently, it has been reported to be associated with poor outcome in diffuse large B-cell lymphoma (DLBCL). The aim of this study was to determine the

Keywords

Keywords: anthracycline; rituximab; adult; aged; article; B cell lymphoma; cancer chemotherapy; cancer palliative therapy; cancer staging; cancer survival; clinical assessment tool; correlational study; diffuse large b cell lymphoma; drug efficacy; female; human; i Diffuse large B cell lymphoma; International prognostic index; Lymphocytopenia; Non-Hodgkin lymphoma; Survival

URI

http://hdl.handle.net/1885/38564

Collections

ANU Research Publications

Source

Leukemia & Lymphoma

Type

Journal article

DOI

10.1080/10428190801959026

Restricted until

2037-12-31

Downloads

File

Description

01_Talaulikar_Lymphocytopenia_as_a_2008.pdf (214.8 KB)

02_Talaulikar_Lymphocytopenia_as_a_2008.pdf (74.65 KB)